Epoetin alfa therapy has dramatically improved therapeutic responses and outcomes for anemic patients with end-stage renal disease. This article examines clinical evidence supporting the correlation between patient outcomes and a higher hematocrit and addresses some of the barriers that may hinder optimal patient outcomes.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
patient outcomes
8
epoetin alfa--focus
4
alfa--focus optimal
4
optimal hematocrit
4
hematocrit case
4
case study
4
study anemic
4
anemic patient
4
patient epoetin
4
epoetin alfa
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!